414 related articles for article (PubMed ID: 35331246)
21. Smart Stimuli-responsive Alginate Nanogels for Drug Delivery Systems and Cancer Therapy: A Review.
Garshasbi HR; Naghib SM
Curr Pharm Des; 2023; 29(44):3546-3562. PubMed ID: 38115614
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices.
Zhang CW; Zhang JG; Yang X; Du WL; Yu ZL; Lv ZY; Mou XZ
Expert Opin Drug Deliv; 2022 Jun; 19(6):623-640. PubMed ID: 35611662
[TBL] [Abstract][Full Text] [Related]
23. Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer.
Lin X; Wu J; Liu Y; Lin N; Hu J; Zhang B
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164213
[TBL] [Abstract][Full Text] [Related]
24. Internal stimuli-responsive nanocarriers for controlled anti-cancer drug release: a review.
Shaik BB; Katari NK; Jonnalagadda SB
Ther Deliv; 2023 Sep; 14(9):595-613. PubMed ID: 37877308
[TBL] [Abstract][Full Text] [Related]
25. Smart Drug Delivery Systems in Cancer Therapy.
Unsoy G; Gunduz U
Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
[TBL] [Abstract][Full Text] [Related]
26. Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review.
Kenchegowda M; Rahamathulla M; Hani U; Begum MY; Guruswamy S; Osmani RAM; Gowrav MP; Alshehri S; Ghoneim MM; Alshlowi A; Gowda DV
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011376
[TBL] [Abstract][Full Text] [Related]
27. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
Lim EK; Chung BH; Chung SJ
Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
[TBL] [Abstract][Full Text] [Related]
28. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
Kapalatiya H; Madav Y; Tambe VS; Wairkar S
Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612
[TBL] [Abstract][Full Text] [Related]
29. [Reactive oxygen species stimuli-responsive nanocarriers].
Zhou W; Yang K; Zhao B; Zhang L; Zhang Y
Se Pu; 2021 Feb; 39(2):118-124. PubMed ID: 34227343
[TBL] [Abstract][Full Text] [Related]
30. Stimuli-sensitive nanopreparations for combination cancer therapy.
Jhaveri A; Deshpande P; Torchilin V
J Control Release; 2014 Sep; 190():352-70. PubMed ID: 24818767
[TBL] [Abstract][Full Text] [Related]
31. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery.
Alrbyawi H; Poudel I; Annaji M; Arnold RD; Tiwari AK; Babu RJ
Pharm Nanotechnol; 2022; 10(1):3-23. PubMed ID: 35156590
[TBL] [Abstract][Full Text] [Related]
32. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
Li L; Yang WW; Xu DG
J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
[TBL] [Abstract][Full Text] [Related]
33. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
Fleige E; Quadir MA; Haag R
Adv Drug Deliv Rev; 2012 Jun; 64(9):866-84. PubMed ID: 22349241
[TBL] [Abstract][Full Text] [Related]
34. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
[TBL] [Abstract][Full Text] [Related]
35. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
Vaghasiya K; Ray E; Singh R; Jadhav K; Sharma A; Khan R; Katare OP; Verma RK
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112027. PubMed ID: 33812642
[TBL] [Abstract][Full Text] [Related]
36. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications.
Ismail EA; Devnarain N; Govender T; Omolo CA
J Control Release; 2022 Dec; 352():1048-1070. PubMed ID: 36372385
[TBL] [Abstract][Full Text] [Related]
37. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
38. Smart pH-Responsive Nanocube-Controlled Delivery of DNA Vaccine and Chemotherapeutic Drugs for Chemoimmunotherapy.
Duong HTT; Thambi T; Yin Y; Lee JE; Seo YK; Jeong JH; Lee DS
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13058-13068. PubMed ID: 30888149
[TBL] [Abstract][Full Text] [Related]
39. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
Saravanakumar K; Hu X; Ali DM; Wang MH
Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
